A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

  1. Llombart-Cussac, A.
  2. Pivot, X.
  3. Biganzoli, L.
  4. Cortes-Funes, H.
  5. Pritchard, K.I.
  6. Pierga, J.-Y.
  7. Smith, I.
  8. Thomssen, C.
  9. Srock, S.
  10. Sampayo, M.
  11. Cortes, J.
Aldizkaria:
Breast

ISSN: 1532-3080,  0960-9776

Argitalpen urtea: 2014

Alea: 23

Zenbakia: 5

Orrialdeak: 656-662

Mota: Artikulua

DOI: 10.1016/J.BREAST.2014.06.017 GOOGLE SCHOLAR lock_openSarbide irekia editor

Objetivos de desarrollo sostenible

Datuen iturria: Scopus